Join to View Full Profile
1250 E Marshall StDept of ImhematologyoncologyRichmond, VA 23298
Phone+1 804-828-7999
Fax+1 804-828-5566
Dr. McGuire is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1973 - 1976
Yale-New Haven Medical CenterResidency, Internal Medicine, 1971 - 1973
Baylor College of MedicineClass of 1971
Certifications & Licensure
VA State Medical License 2012 - 2026
TX State Medical License 1971 - 2014
MD State Medical License 1974 - 2013
IL State Medical License 1979 - 1987
CT State Medical License 1972 - 1979
DC State Medical License 1976 - 1977
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer Start of enrollment: 2000 Jul 01
- Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer Start of enrollment: 2001 Jan 01
Publications & Presentations
PubMed
- 3 citationsCommentary on "Enteral Lactoferrin Supplementation for Prevention of Sepsis and Necrotizing Enterocolitis in Preterm Infants".Lauren Young, William McGuire, Peter W Fowlie
Neonatology. 2021-02-09 - 11 citationsELFIN, the United Kingdom preterm lactoferrin trial: interpretation and future questions 1.Janet E. Berrington, William McGuire, Nicholas D. Embleton
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire. 2021-02-01 - 3 citationsParental experiences of being approached to join multiple neonatal clinical trials: Qualitative study (PARENT)Judy Richards, Judith Rankin, Ed Juszczak, Jon Dorling, William McGuire
Archives of Disease in Childhood. Fetal and Neonatal Edition. 2021-01-01
Press Mentions
First Patient Enrolled in OncoQuest's Phase 1/2 Study Combining Oregovomab with Hiltonol® in Recurrent Ovarian CancerJuly 26th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
